Reduction in p48-ISGFγ levels confers resistance to Interferon-α_2a in MHCC97 cellsWU, Wei-Zhong; SUN, Hui-Chuan; GAO, Yan-Qin et al.Oncology. 2004, Vol 67, Num 5-6, pp 428-440, issn 0030-2414, 13 p.Article

Phase I-II study of the addition of α-2a interferon to 5-fluorouracil/leucovorin. Pharmacokinetic interaction of α-2a interferon and leucovorinSINNIGE, H. A. M; BUTER, J; DE VRIES, E. G. E et al.European journal of cancer. Part A. 1993, Vol 29, Num 12, pp 1715-1720Article

Genes transcriptionally modulated by interferon α2a correlate with the cytokine activityIOLASCON, Achille; VOLINIA, Stefano; INDACO, Stefania et al.Haematologica (Roma). 2004, Vol 89, Num 9, pp 1046-1053, issn 0390-6078, 8 p.Article

Fermentation process optimization of recombinant Saccharomyces cerevisiae for the production of human interferon-α2aJU CHU; SILIANG ZHANG; YINGPING ZHUANG et al.Applied biochemistry and biotechnology. 2003, Vol 111, Num 3, pp 129-137, issn 0273-2289, 9 p.Article

Temperature- and pH-induced multiple partially unfolded states of recombinant human interferon-α2a: Possible implications in protein stabilitySHARMA, Vikas K; KALONIA, Devendra S.Pharmaceutical research. 2003, Vol 20, Num 11, pp 1721-1729, issn 0724-8741, 9 p.Article

Differential efficacy of human recombinant interferon-α2a on ocular and extraocular manifestations of Behçet disease: Results of an open 4-center trialKÖTTER, Ina; VONTHEIN, Reinhard; ZIERHUT, Manfred et al.Seminars in arthritis and rheumatism. 2004, Vol 33, Num 5, pp 311-319, issn 0049-0172, 9 p.Article

Validation of an RP-LC Method for the Determination of Interferon-a2a in Pharmaceutical FormulationsMAGALHAES DA SILVA, Lucélia; BIZOGNE SOUTO, Ricardo; DA SILVA SANGOI, Maximiliano et al.Journal of liquid chromatography & related technologies. 2009, Vol 32, Num 1-4, pp 370-382, issn 1082-6076, 13 p.Article

Randomized placebo-controlled double-blind combined therapy with laser surgery and systemic interferon-α2a in the treatment of anogenital condylomata acuminatumThe Journal of infectious diseases. 1993, Vol 167, Num 4, pp 824-829, issn 0022-1899Article

Treatment of chronic hepatitis C with recombinant human interferon-α_2a : results of a randomized controlled clinical trialDIODATI, G; BONETTI, P; REALDI, G et al.Hepatology (Baltimore, Md.). 1994, Vol 19, Num 1, pp 1-5, issn 0270-9139Article